Company: ICUI
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0000883984-25-000010
Chunk: 69

Company: ICU MEDICAL INC/DE
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 69
---
ive Plan (as amended, the “Plan”), which (i) increases the number of shares available under the Plan by 2,150,000 shares of common stock, and (ii) increases the number of shares which may be granted as incentive stock options (“ISOs”) under the Plan by 2,150,000 shares of common stock (the “Amendment”).

The Amendment is subject to stockholder approval. If approved by our stockholders, the Amendment will become effective as of the date the Board adopted the Amendment. The Board recommends that you vote “ FOR ” the approval of the Amendment.

Within this Proposal 2, we refer to the Plan, as amended by the Amendment, as the “Amended Plan”.

Proposed Share Reserve Increase and Shares Available for Issuance

We are asking our stockholders to approve the Amendment because we believe the availability of an adequate reserve of shares under the Plan is an integral part of our compensation program, as well as our continued growth and success. The Plan was structured to provide the Company with the necessary flexibility to design long‑term incentive programs for our employees that align with our compensation philosophy, and more effectively support the strategic priorities of our organization. The equity‑based awards issued under the Plan increase our ability to attract, motivate, and retain high quality talent, as providing equity‑based awards is critical to achieving success as we compete for talent in an industry in which equity compensation is market practice and is expected by many existing personnel and prospective candidates. Further, we believe that grants of equity‑based incentive awards are necessary to enable us to design and implement executive compensation programs that retain our key employees, compensate those employees based on the performance of the Company and other individual performance factors and align the goals and objectives of our employees with the interests of our stockholders. If the Amendment is not approved, we believe these goals will be adversely affected.

The Amendment increases the aggregate Plan share limit by 2,150,000 shares to 8,515,510 shares of common stock. To the extent we grant any awards under the Plan between March 8, 2025, and the date of this Annual Meeting, the available share reserve under the Amended Plan will be reduced from 2,621,252 shares (i.e., the remaining available reserve as of March 8, 2025 (471,252) shares, plus 2,150,000 shares) by the number of shares that we grant under the Plan during such period.

Set forth below is the number of shares